Delivery Order SPE2DE21D7020-SPE2D625F8SD4
- Not listed
- This federal contract award was issued by the Defense Health Agency (DHA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The $3,796.55 fixed-price with economic price adjustment delivery order contract is for the provision of ENROUTE TCAR STENTS, which are specialized medical devices used in cardiovascular procedures. The contract has an ultimate completion date of July 16, 2025 and was awarded on July 9, 2025. It is not designated...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for the delivery of ENROUTE TCAR stents. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and a ceiling value of $3,796.55. The contract does not have a set-aside designation. The performance period extends to June 10, 2025. Boston Scientific is also the holder of two federal Indefinite Delivery Vehicles (IDVs) with...
- Boston Scientific Corp has been awarded a delivery order valued at $12,099.85 for the ENROUTE NPS PLUS product under a fixed price contract with economic price adjustment provisions. The award was issued on June 30, 2025, with an ultimate completion date of July 8, 2025. The contract is funded by the Defense Health Agency's Medical Supply Chain and performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was not issued under a set-aside program, indicating...
- This is a $8,000 fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract is for the delivery of TAVR EMB PROTECTION products, which are likely cardiovascular medical devices used in transcatheter aortic valve replacement (TAVR) procedures. The order does not have a set-aside designation and is expected to be completed by August 20, 2024. Boston Scientific is...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- This is a $16,000 fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency to Boston Scientific Corp, a leading medical device manufacturer. The contract is for the delivery of TAVR EMB PROTECTION products, which are likely related to transcatheter aortic valve replacement (TAVR) procedures and associated embolic protection devices. The award has an ultimate completion date of May 7, 2024. Boston Scientific has received numerous federal contract...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for medical supply chain items. The contract is a Delivery Order with a ceiling value of $1,832.60 and a fixed price with economic price adjustment pricing type. The contract was not set aside for any specific business types. The award date is June 10, 2025, with a final completion date of June 17, 2025. Boston Scientific Corp is the prime contractor for this...
- This delivery order, awarded June 25, 2025, to Boston Scientific Corp through the Defense Health Agency's Medical Supply Chain, covers the procurement of detachable coils with a ceiling value of $13,134.40 and an ultimate completion date of July 2, 2025. Boston Scientific, a global medical technology company headquartered in Marlborough, Massachusetts, will perform the work at its Marlborough facility. The contract utilizes fixed-price pricing with economic price adjustment and was awarded...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $4,154.85 by the Defense Health Agency's Medical Supply Chain on July 25, 2025, for the NC EMERGE MR 30MM product. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 1, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award represents a non-set-aside procurement,...
- This is a federal contract award to Boston Scientific Corp, a leading manufacturer of medical devices, by the Defense Health Agency (DHA) under the Medical Supply Chain program. The contract, valued at $3,717.20, is a delivery order for the supply of various medical products, including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems, drug-coated balloons, catheters, stents, and surgical implants. The contract has a fixed...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F8SD4Delivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $3,326.30 to Boston Scientific Corp for EnRoute TCAR stents on July 25, 2025, with an ultimate completion date of August 1, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes its extensive portfolio of cardiovascular intervention devices. Boston Scientific Corp, a global leader in medical device innovation, serves as a prime contractor across multiple federal healthcare agencies, supplying specialized cardiovascular and interventional medical technologies including stents, catheters, and diagnostic tools. This delivery order represents one of many awards the company has received through the Defense Health Agency and Department of Veterans Affairs, reflecting its established role as a critical supplier within the federal medical device supply chain. The EnRoute TCAR stents represent the company's specialized offerings in neurointerventional devices used for carotid artery treatment, supporting the Defense Health Agency's mission to provide advanced medical capabilities to the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/25/25 |